Showing results (61-70 of 183) with videos related to
Sort By:
Pageof 19
Neuro-Oncology|September 2, 2015
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective studyRoberta Rudà, Chiara Bosa, Michela Magistrello, et al.World Neurosurgery|November 30, 2018
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical SeriesFederico Pessina, Pierina Navarria, Elena Clerici, et al.Journal of Neuro-Oncology|April 30, 2017
Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across EuropeEmilie Le Rhun, Roberta Rudà, Patrick Devos, et al.Journal of Neuropathology and Experimental Neurology|March 17, 2009
Caveolin 1 expression independently predicts shorter survival in oligodendrogliomasRebecca Senetta, Elisa Trevisan, Roberta Rudà, et al.Journal of Cancer Research and Clinical Oncology|January 23, 2015
Meningiomas after cranial radiotherapy for childhood cancer: a single institution experienceFrancesco Felicetti, Nicoletta Fortunati, Diego Garbossa, et al.Neuro-Oncology|July 31, 2013
Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective studyRoberta Rudà, Umberto Magliola, Luca Bertero, et al.Melanoma Research|October 26, 2021
Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lessonMichele Parietti, Elena Marra, Simone Ribero, et al.Brain Sciences|May 28, 2022
Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival: A Single Institution ExperienceFrancesco Bruno, Alessia Pellerino, Edoardo Pronello, et al.Oncotarget|April 7, 2016
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomasEleonora Duregon, Luca Bertero, Alessandra Pittaro, et al.Neuro-Oncology|November 19, 2015
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomasUlrich Roelcke, Matthias T Wyss, Martha Nowosielski, et al.Pageof 19